These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 16373540)

  • 1. Breakthrough of the year: scorecard 2004.
    Science; 2005 Dec; 310(5756):1880. PubMed ID: 16373540
    [No Abstract]   [Full Text] [Related]  

  • 2. Breakthrough of the year. Scorecard.
    Science; 2008 Dec; 322(5909):1770-1. PubMed ID: 19095906
    [No Abstract]   [Full Text] [Related]  

  • 3. Breakthrough of the year. Scorecard 2006.
    Science; 2006 Dec; 314(5807):1850-1. PubMed ID: 17185567
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring and monitoring IT using a balanced scorecard approach.
    Gash DJ; Hatton T
    J Healthc Inf Manag; 2007; 21(2):60-6. PubMed ID: 17583169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steps toward an automated scorecard system.
    Johnson M
    Healthc Financ Manage; 2006 Feb; 60(2):84-8, 90. PubMed ID: 16519216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metric to evaluate the comparative performance of an institution's graduate medical education program.
    Murray PM; Valdivia JH; Berquist MR
    Acad Med; 2009 Feb; 84(2):212-9. PubMed ID: 19174668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.S. health system performance: a national scorecard.
    Schoen C; Davis K; How SK; Schoenbaum SC
    Health Aff (Millwood); 2006; 25(6):w457-75. PubMed ID: 16987933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative performance scorecard for federally funded community health centers in North Carolina.
    Radford A; Pink G; Ricketts T
    J Healthc Manag; 2007; 52(1):20-31; discussion 32-3. PubMed ID: 17288115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous morphine for breakthrough (episodic-) pain in an acute palliative care unit: a confirmatory study.
    Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; Mangione S
    J Pain Symptom Manage; 2008 Mar; 35(3):307-13. PubMed ID: 18178368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How safe is my intensive care unit? Methods for monitoring and measurement.
    Berenholtz SM; Pustavoitau A; Schwartz SJ; Pronovost PJ
    Curr Opin Crit Care; 2007 Dec; 13(6):703-8. PubMed ID: 17975394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon beta-1a: analysis of the PRISMS study.
    Freedman MS; Forrestal FG
    Mult Scler; 2008 Nov; 14(9):1234-41. PubMed ID: 18632774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough of the year. Global warming, hotter than ever.
    Kintisch E; Kerr RA
    Science; 2007 Dec; 318(5858):1846-7. PubMed ID: 18096774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough pain in children with cancer.
    Friedrichsdorf SJ; Finney D; Bergin M; Stevens M; Collins JJ
    J Pain Symptom Manage; 2007 Aug; 34(2):209-16. PubMed ID: 17553659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact and management of breakthrough pain in cancer.
    Zeppetella G
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):1-6. PubMed ID: 19365156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal sufentanil for cancer-associated breakthrough pain.
    Good P; Jackson K; Brumley D; Ashby M
    Palliat Med; 2009 Jan; 23(1):54-8. PubMed ID: 19144765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational study of oncology patients' utilization of breakthrough pain medication.
    Davies AN; Vriens J; Kennett A; McTaggart M
    J Pain Symptom Manage; 2008 Apr; 35(4):406-11. PubMed ID: 18222631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of protein breakthrough performance in cryogel columns by taking into account the overall axial dispersion.
    Yun J; Kirsebom H; Galaev IY; Mattiasson B
    J Sep Sci; 2009 Aug; 32(15-16):2601-7. PubMed ID: 19630009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome.
    Manolakopoulos S; Bethanis S; Elefsiniotis J; Karatapanis S; Triantos C; Sourvinos G; Touloumi G; Economou M; Vlachogiannakos J; Spandidos D; Avgerinos A; Tzourmakliotis D
    Aliment Pharmacol Ther; 2006 Mar; 23(6):787-95. PubMed ID: 16556181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of HBV DNA level and viral breakthrough during lamivudine therapy for chronic hepatitis B].
    Park HS; Lee DH; Heo J; Kim GH; Kang DH; Song GA; Cho M
    Korean J Hepatol; 2006 Jun; 12(2):173-83. PubMed ID: 16804342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.